News dal mondo
Further NDMA contamination discovery prompts lawsuit
Both the FDA and EMA announce NDMA contamination of ranitidine medicines and a lawsuit is immediately filed against manufacturers for ‘concealing’...
MHRA Updates Guidance on ‘No-Deal’ Brexit Scenario
The UK’s Medicines and Healthcare Products Regulator Agency updated its guidance for how medicines will be regulated in the event of a “no-deal”...
FDA Offers More Time to Join Quality Metrics Feedback Program
The FDA has reopened the submission period for its quality metrics feedback program, giving potential participants more time to sign up.
The CDMO Evolution
The evolution of CDMOs has led to increased investment in new technologies, capabilities, and expertise...[PharmTech]